Neuraxpharm CEO Confirms Expansion Into New Markets, Including US

Company’s Value-Added Segment Expected To Soon Account For Half Of Sales

Neuraxpharm CEO
Neuraxpharm’s Dierks talks about international expansion and becoming a European leader in Medical Cannabis • Source: Neuraxpharm
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business